EXC
56
-2
DTE
52
5
BAX
44
-3
WRK
60
-2
FCX
61
-2
UNM
66
-4
BF.B
50
-3
ROK
52
-4
SCHW
56
4
HRL
35
2
AAP
26
3
BSX
64
2
TSCO
50
2
PSA
28
-10
KMB
45
3
BWA
48
-2
BLK
41
-2
A
41
-3
SRCL
41
-3
AEE
32
-3
EXC
56
-2
DTE
52
5
BAX
44
-3
WRK
60
-2
FCX
61
-2
UNM
66
-4
BF.B
50
-3
ROK
52
-4
SCHW
56
4
HRL
35
2
AAP
26
3
BSX
64
2
TSCO
50
2
PSA
28
-10
KMB
45
3
BWA
48
-2
BLK
41
-2
A
41
-3
SRCL
41
-3
AEE
32
-3
Financhill
Back

Voyager Therapeutics Vs. Neurocrine Biosciences Industry Stock Comparison

Sell
44

VYGR
Voyager Therapeutics

Last Price:
7.76
Seasonality Move:
7.86%
Buy
64

NBIX
Neurocrine Biosciences

Last Price:
133.30
Seasonality Move:
9.97%
Sell
44
Voyager Therapeutics (VYGR) is a Sell

Is Voyager Therapeutics a Buy, Sell or Hold?

  • The current Voyager Therapeutics [VYGR] share price is $7.97. The Score for VYGR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • VYGR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Neurocrine Biosciences (NBIX) is a Buy

Is Neurocrine Biosciences a Buy, Sell or Hold?

  • The current Neurocrine Biosciences [NBIX] share price is $132.99. The Score for NBIX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • NBIX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VYGR Stock Price Chart

What is Voyager Therapeutics's stock price today?

  • The Voyager Therapeutics share price today is $7.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VYGR is experiencing selling pressure, which indicates risk of future bearish movement.

NBIX Stock Price Chart

What is Neurocrine Biosciences's stock price today?

  • The Neurocrine Biosciences share price today is $132.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing slight selling pressure.

VYGR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 38.16 Sell
Chaikin Money Flow: -317918 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.66 - 9.84) Sell
Bollinger Bands (100): (7.36 - 9.28) Sell

NBIX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.85 Sell
Relative Strength Index (14 RSI): 39.74 Sell
Chaikin Money Flow: -192957 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (135.95 - 141.33) Sell
Bollinger Bands (100): (123.48 - 140.88) Buy

VYGR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.72 Sell
20-day SMA: 9.28 Sell
50-day SMA: 8.74 Sell
200-day SMA: 8.34 Sell
8-day EMA: 8.62 Sell
20-day EMA: 8.96 Sell
50-day EMA: 8.81 Sell
200-day EMA: 8.38 Sell

NBIX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 136.36 Sell
20-day SMA: 138.44 Sell
50-day SMA: 136.55 Sell
200-day SMA: 119.78 Buy
8-day EMA: 135.41 Sell
20-day EMA: 137 Sell
50-day EMA: 136.13 Sell
200-day EMA: 123.63 Buy

Voyager Therapeutics Earnings Growth & VYGR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.11 per share, a decrease this year of $3.25 per share, and an increase next year of $0.04 per share.

Neurocrine Biosciences Earnings Growth & NBIX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.86 per share, and an increase next year of $1.78 per share.

Voyager Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurocrine Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):